Treatment satisfaction is associated with improved quality of life in patients treated with inhaled treprostinil for pulmonary arterial hypertension

BACKGROUND: Patient treatment satisfaction is likely to be a highly relevant outcome measure in pulmonary arterial hypertension (PAH), a condition for which the benefits of treatment must be weighed against frequent, undesirable side effects, inconvenience, and complications associated with therapy....

詳細記述

保存先:
書誌詳細
主要な著者: Chen, Hubert, Rosenzweig, Erika B, Gotzkowsky, S Karl, Arneson, Carl, Nelsen, Andrew C, Bourge, Robert C
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2013
主題:
Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3610124/
https://ncbi.nlm.nih.gov/pubmed/23496856
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1477-7525-11-31
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料